NCT06108024 - A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

September 15, 2024

Study Completion Date

October 15, 2024

Conditions

Seborrheic Keratosis

Interventions

DRUG

SM-020 gel 1.0%

SM-020 gel 1.0% will be applied topically. Subjects will be treated with twice daily application to 5 to 10 SKTLs for approximately 28 days.

DRUG

Vehicle gel

Vehicle gel will be applied topically. Subjects will be treated with twice daily application to 5 to 10 SKTLs for approximately 28 days.

Trial Locations (4)

RECRUITING

Driven Research LLC, Coral Gables

RECRUITING

Minnesota Clinical Study Center, New Brighton

RECRUITING

Oregon Medical Research Center, Portland

RECRUITING

Oregon Dermatology and Research Center, Portland